Insider filing · NUVL
Henry E. Pelish
Chief Scientific Officer
profile →
Nuvalent Inc
NUVL · Healthcare · 94 filings in 24 months
ticker →
Henry E. Pelish sold $412K of Nuvalent (NUVL)
Executed Aug 7 2025, disclosed Aug 8 2025, 1 day later.
Value, as filed
$412K
5,500 sh × $74.85
Executed
Aug 7 2025
the trade date, as filed
Disclosed
Aug 8 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
HPHenry E. Pelish (Chief Scientific Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Nuvalent Inc (NUVL). The largest single filing was $3.3M of NUVL (33,994 sh across 4 lots, as filed), executed Mar 12.
The name
NUVLHealthcare · Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Henry E. Pelish in NUVL
NUVLSALE
Nuvalent Inc
$261K2,111 sh × $123.81
Exec Jul 9
Filed Jul 10 · 4:30 PM ET NUVLSALE Nuvalent Inc $229K
2,193 sh × $104.27
Exec Apr 9
Filed Apr 13 · 5:30 PM ET NUVLSALE Nuvalent Inc $3.3M
33,994 sh across 4 lots
Exec Mar 12
Filed Mar 16 · 5:30 PM ET NUVLSALE Nuvalent Inc $352K
3,612 sh across 3 lots
Exec Jan 5
Filed Jan 7 · 5:30 PM ET NUVLSALE Nuvalent Inc $1.3M
14,205 sh × $90.04
Exec Oct 15 2025
Filed Oct 17 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc $686K
7,637 sh × $89.81
Exec Oct 13 2025
Filed Oct 15 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc $294K
3,725 sh × $78.83
Exec Sep 10 2025
Filed Sep 12 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc $578K
7,205 sh across 2 lots
Exec Jul 9 2025
Filed Jul 11 2025 · 5:30 PM ET